Overview

OSU-CATS: Overview 

The overall theme of The Ohio State University Center for the Advancement of Tobacco Science (OSU-CATS) application is to provide real world and complementary experimental scientific evidence to support tobacco control policies that impact tobacco use and risk, specifically considering factors that are market-focused factors (e.g., pricing, flavor, advertisements), product-focused factors (e.g., regulation of flavored products and electronic nicotine delivery systems (ENDS), such as electronic cigarettes and tobacco products that heat and not burn) and user-focused factors (e.g., access to tobacco products and cessation treatment).

OSU-CERTS: Overview - The infrasctructure in which OSU-CATS is built upon.  

One of 14 Tobacco Control Regulatory Centers in the U.S.

Goal: Serve as a national leader in providing relevant scientific data to support regulatory decision making at the FDA’s Center for Tobacco Products

  • Train students/postdoctoral researchers in the field of tobacco regulatory science
  • Provide start-up funding for pilot projects 

Overall Theme:  Initiation and uptake of tobacco products

  • Areas of emphasis:
    • Urban and rural adolescents and adults
    • Dual tobacco product use
    • Toxic exposures to tobacco products
    • Genetic susceptibilities to tobacco products
    • Tobacco product dependence and quitting behaviors
    • Advertising and marketing of tobacco products
    • Decision-making about tobacco product preferences 

Twenty faculty members from seven OSU colleges and the Comprehensive Cancer Center (OSUCCC) composed the core of OSU-CERTS.

OSU-CERTS Research Projects

The Ohio State University, Center of Excellence in Regulatory Tobacco Science (OSU-CERTS), is supported by grant number P50CA180908 from the National Cancer Institute, National Institutes of Health and Food and Drug Administration Center for Tobacco Products (CTP). The content in this website is solely the responsibility of OSU-CERTS and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration.